Skip to main content

Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus

2025-08-26 10:15

Following the publication yesterday of Ortivus’ interim report for the period 1 January – 30 June 2025, the company’s main shareholder, Ponderus Invest, has resolved to extend the existing credit facility to Ortivus by an additional SEK 10 million, a proposal which the company has accepted.

The additional lending may be drawn upon as required and carries the same terms as the previous loans, namely an interest rate of 8 per cent from the respective drawdown date. Repayment of any amounts utilised shall be made no later than 28 February 2026.

Prior to this extension, Ortivus’ borrowings from Ponderus Invest under the credit facility amounted to SEK 47.5 million.

The new facility provides the company with the necessary financial flexibility to continue product development and to pursue a more proactive market strategy, as outlined in yesterday’s interim report.

Get in touch

Empower your team with smarter tools

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required